Ticagrelor Related Compound 15
|
|
Ticagrelor Related Compound 15 속성
- 밀도
- 1.87±0.1 g/cm3(Predicted)
- 용해도
- DMSO(약간 용해됨), 메탄올(약간 용해됨)
- 산도 계수 (pKa)
- 9.08±0.40(Predicted)
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 색상
- 흰색에서 황백색까지
- 안정성
- 흡습성
안전
Ticagrelor Related Compound 15 C화학적 특성, 용도, 생산
용도
5-Desthiopropyl-5-hydroxy-ticagrelor is a related compound of ticagrelor (T437700). Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).Ticagrelor Related Compound 15 준비 용품 및 원자재
원자재
준비 용품
Ticagrelor Related Compound 15 공급 업체
글로벌( 29)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14336 | 58 |
CR Corporation Lomited | |
fred.wen@crcorporation.cn | CHINA | 12069 | 58 |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11927 | 58 |
ChemStrong Scientific Co.,Ltd | 0755-0755-66853366 13670046396 |
sales@chem-strong.com | China | 18021 | 56 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 8286 | 55 |
Shanghai CR Corporation Limited | 021-80270511; 4006653949 |
fred.wen@crcorporation.cn | China | 10047 | 58 |
Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 |
sales@rrkchem.com | China | 56077 | 58 |
BOC Sciences | -- |
info@bocsci.com | USA | 0 | 65 |
Guangzhou Dreampharm Biotechnology Co., Ltd. | 020-36607679 17825480238 |
3008233717@qq.com | China | 9875 | 12 |
Tianjin shijia biomedical technology co., LTD | 15022261580 |
tjshj1212@163.com | China | 2435 | 58 |
Ticagrelor Related Compound 15 관련 검색:
Ticagrelor Sulfone
2-[[(3aR,4S,6R,6aS)-6-(7-azanyl-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol
1,2-Cyclopentanediol, 3-[7-aMino-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyriMidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-
Ticagrelor Related Compound 3 ((+/-)-6-Aminotetrahydro-2,2-Dimethyl-4H-Cyclopenta-1.3-dioxol-4-ol)
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
(1S,2R)-2-(3,4-Difluorophenyl)-cyclopropanaMine
Ticagrelor Related Compound 70 HCl
(1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Related Compound 27 Oxalate
Ticagrelor diastereoMer
Ticagrelor Related Compound 44
CyclopropanaMine, 2-(4-fluorophenyl)-(hydrochloride)(1:1),(1R,2S)-
Ticagrelor Sulphone
Ticagrelor-d7
Ticagrelor Related Compound 94 HCl
2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
2-(3,4-difluorophenyl)oxirane
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanaMine hydrochloride